Valent, Peter
Akin, Cem
Arock, Michel
Funding for this research was provided by:
Austrian Science Fund (P32470-B)
Medical University of Vienna
Article History
Accepted: 3 January 2024
First Online: 3 February 2024
Compliance with Ethical Standards
:
: Peter Valent: received 1. a research grant from AOP Orphan and Celgene (BMS), and 2. consultancy honoraria from Novartis, Celgene, AOP Orphan, Blueprint, Pfizer, Stemline, and Cogent. Cem Akin: received 1. a research grant from Blueprint and Cogent, and 2. consultancy honoraria from Blueprint, Cogent, and Novartis. Michel Arock received 1. a research grant from Blueprint, and 2. consultancy honoraria from AB Science, Blueprint, Novartis, and ThermoFisher.
: This article does not contain any studies with human or animal subjects.
: The Fig. InternalRef removed is an original Figure and has never been published before.